Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Allergan's novel glaucoma drug nears clinical trials

Nov. 2, 2000

Update on Pharmacia's ocular medications

Oct. 24, 2000

Protective effect demonstrated for SKK-60060 in rat model of retinal ischemia-reperfusion

Oct. 23, 2000

Ciba Vision and QLT seek to expand Visudyne indication in the E.U.

Oct. 5, 2000

New series from Senju particularly useful for ocular disorders

Oct. 4, 2000

New ocular hypotensive agents in the Alcon pipeline

Sep. 8, 2000

New agents for glaucoma reported by Santen

Sep. 4, 2000

Visudyne sNDA granted priority review status

Sep. 1, 2000

Inspire reports synthesis of more stable P2Y2 agonists

Aug. 30, 2000

Allergan in-licenses gatifloxacin from Kyorin for treatment of ocular infections

Aug. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...